The high court will grant cert. -- as this statement of the issue presented. . . essentially answers itself.
The docs must fail; Danco Labs and the FDA must prevail:
. . .In 2000, the Food and Drug Administration (FDA) approved Danco’s drug Mifeprex for termination of early pregnancy based on the agency’s expert judgment that clinical data showed the drug to be safe and effective.
The agency later modified certain conditions of use for mifepristone in 2016 and 2021, again relying on clinical data and the agency’s expert judgment that the drug would remain safe and effective under the modified conditions of use. In 2022, associations of doctors who have never prescribed Mifeprex sued FDA, arguing that FDA’s actions modifying the drug’s conditions of use in 2016 and 2021 violated the Administrative Procedure Act. . . .
Now you know. Falling silent for about a week. Cheers.
नमस्ते
2 comments:
Alea iacta est!
Videbimus; fortasse nondum. . . .
Post a Comment